vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Ally金融（SPFI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Ally金融的1.4倍（$75.5M vs $54.1M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.6%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Ally金融是一家注册于特拉华州的美国银行控股公司，总部位于密歇根州底特律市的Ally底特律中心。该公司提供多元金融服务，涵盖汽车融资、直营网络银行、企业贷款、车辆保险、按揭贷款，以及分期销售、租赁协议等相关融资服务。
PBYI vs SPFI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$54.1M
两年增速更快
PBYI
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $54.1M |
| 净利润 | — | $14.5M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 26.9% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | 18.3% |
| 每股收益（稀释后） | $0.26 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISPFI
| Q1 26 | — | $54.1M | ||
| Q4 25 | $75.5M | $53.9M | ||
| Q3 25 | $54.5M | $54.2M | ||
| Q2 25 | $52.4M | $54.7M | ||
| Q1 25 | $46.0M | $49.2M | ||
| Q4 24 | $59.1M | $51.9M | ||
| Q3 24 | $80.5M | $47.9M | ||
| Q2 24 | $47.1M | $48.6M |
净利润PBYISPFI
| Q1 26 | — | $14.5M | ||
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $16.3M | ||
| Q2 25 | $5.9M | $14.6M | ||
| Q1 25 | $3.0M | $12.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $11.2M | ||
| Q2 24 | $-4.5M | $11.1M |
毛利率PBYISPFI
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
营业利润率PBYISPFI
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | 35.4% | ||
| Q3 25 | 17.6% | 38.1% | ||
| Q2 25 | 12.7% | 34.1% | ||
| Q1 25 | 8.7% | 31.9% | ||
| Q4 24 | 22.6% | 39.9% | ||
| Q3 24 | 27.4% | 29.8% | ||
| Q2 24 | -4.6% | 29.3% |
净利率PBYISPFI
| Q1 26 | — | 26.9% | ||
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 30.1% | ||
| Q2 25 | 11.2% | 26.7% | ||
| Q1 25 | 6.5% | 25.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 23.4% | ||
| Q2 24 | -9.6% | 22.9% |
每股收益（稀释后）PBYISPFI
| Q1 26 | — | — | ||
| Q4 25 | $0.26 | $0.90 | ||
| Q3 25 | $0.17 | $0.96 | ||
| Q2 25 | $0.12 | $0.86 | ||
| Q1 25 | $0.06 | $0.72 | ||
| Q4 24 | $0.40 | $0.96 | ||
| Q3 24 | $0.41 | $0.66 | ||
| Q2 24 | $-0.09 | $0.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $722.0M |
| 总债务越低越好 | $22.7M | $3.0K |
| 股东权益账面价值 | $130.3M | $504.9M |
| 总资产 | $216.3M | $4.6B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资PBYISPFI
| Q1 26 | — | $722.0M | ||
| Q4 25 | $97.5M | $552.4M | ||
| Q3 25 | $94.4M | $635.0M | ||
| Q2 25 | $96.0M | $470.5M | ||
| Q1 25 | $93.2M | $536.3M | ||
| Q4 24 | $101.0M | $359.1M | ||
| Q3 24 | $96.7M | $471.2M | ||
| Q2 24 | $96.8M | $298.0M |
总债务PBYISPFI
| Q1 26 | — | $3.0K | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
股东权益PBYISPFI
| Q1 26 | — | $504.9M | ||
| Q4 25 | $130.3M | $493.8M | ||
| Q3 25 | $115.3M | $477.8M | ||
| Q2 25 | $104.7M | $454.1M | ||
| Q1 25 | $97.1M | $443.7M | ||
| Q4 24 | $92.1M | $438.9M | ||
| Q3 24 | $71.1M | $443.1M | ||
| Q2 24 | $48.5M | $418.0M |
总资产PBYISPFI
| Q1 26 | — | $4.6B | ||
| Q4 25 | $216.3M | $4.5B | ||
| Q3 25 | $202.9M | $4.5B | ||
| Q2 25 | $194.9M | $4.4B | ||
| Q1 25 | $196.2M | $4.4B | ||
| Q4 24 | $213.3M | $4.2B | ||
| Q3 24 | $220.7M | $4.3B | ||
| Q2 24 | $205.0M | $4.2B |
负债/权益比PBYISPFI
| Q1 26 | — | 0.00× | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | — |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYISPFI
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $77.5M | ||
| Q3 25 | $9.7M | $24.2M | ||
| Q2 25 | $14.1M | $14.7M | ||
| Q1 25 | $3.6M | $26.1M | ||
| Q4 24 | $15.6M | $59.4M | ||
| Q3 24 | $11.0M | $17.9M | ||
| Q2 24 | $1.0M | $18.2M |
自由现金流PBYISPFI
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $71.8M | ||
| Q3 25 | $9.7M | $22.5M | ||
| Q2 25 | $14.1M | $13.0M | ||
| Q1 25 | $3.6M | $25.0M | ||
| Q4 24 | $15.6M | $56.0M | ||
| Q3 24 | $11.0M | $17.1M | ||
| Q2 24 | $1.0M | $17.1M |
自由现金流率PBYISPFI
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 133.3% | ||
| Q3 25 | 17.7% | 41.5% | ||
| Q2 25 | 26.8% | 23.8% | ||
| Q1 25 | 7.7% | 50.8% | ||
| Q4 24 | 26.4% | 108.0% | ||
| Q3 24 | 13.7% | 35.7% | ||
| Q2 24 | 2.1% | 35.2% |
资本支出强度PBYISPFI
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 10.5% | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.1% | 2.3% | ||
| Q4 24 | 0.0% | 6.5% | ||
| Q3 24 | 0.0% | 1.6% | ||
| Q2 24 | 0.0% | 2.2% |
现金转化率PBYISPFI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 1.48× | ||
| Q2 25 | 2.41× | 1.01× | ||
| Q1 25 | 1.21× | 2.12× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 1.59× | ||
| Q2 24 | — | 1.63× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
SPFI
| Net Interest Income | $42.9M | 79% |
| Noninterest Income | $11.3M | 21% |
